Betere patiënt-dokter dialoog over palliatieve zorg en deelname aan vroeg-klinische studies door online te verhelderen wat een patiënt belangrijk vindt
- Conditions
- Early phase clinical trialPalliative careValue clarification toolPatient-physician communication
- Registration Number
- NL-OMON27139
- Lead Sponsor
- Erasmus MC, RotterdamAntoni van Leeuwenhoek, AmsterdamUMC Utrecht
- Brief Summary
https://bmcpalliatcare.biomedcentral.com/articles/10.1186/s12904-019-0486-6
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- Not specified
- Target Recruitment
- 314
Inclusion Criteria
For the patients:
- Diagnosed with advanced cancer for whom standard systemic therapy is not or no longer available;
Exclusion Criteria
For the patients:
- Cognitive impairment (e.g. dementia) according to the medical record;
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method For WP1, the main study endpoint will be the delivery of a ready to implement online value clarification tool. For WP2 this will be decisional conflict measured by the Dutch version of the Decisional Conflict Scale (DCS).
- Secondary Outcome Measures
Name Time Method Secondary study parameters for WP1 include the life values of patients, experiences with patient-physician communication, and<br>the fit and value of the online value clarification tool.<br /><br>Secondary outcomes for WP2 include the communication process, decision making process, discussion of patients’ values and<br>preferences, consultation duration, and actual usage of the tool.